Family · Pharmaceutical analytical standards
Voriconazole
A second-generation triazole antifungal, approved in the United States in 2002 and mainly used for invasive aspergillosis and other serious fungal infections, such as those caused by Scedosporium and Fusarium. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a structural relative of fluconazole but with a much broader spectrum: it also acts on moulds such as Aspergillus and on some fluconazole-resistant Candida species, such as C. krusei.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
